LORAZEPAM Leman cpr 2.5 mg 20 pce

7680702350097 CH-70235 N05BA06 01.04.1.

Active substances:

No images available

Details

Product number
7023502
CPT
-
Packaging group
20
Unit
Tablette(n)
Composition
lorazepamum 2.5 mg, lactosum monohydricum 120 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, pro compresso corresp. natrium 0.25 mg.

Articles (1)

Lorazepam Leman 2.5 mg, comprimés
Tabletten
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/02/2026
Patient information leaflet
Français
07/02/2026
Patient information leaflet
Italien
07/02/2026
Professional SmPC
Allemand
07/02/2026
Professional SmPC
Français
07/02/2026
Professional SmPC
Italien
07/02/2026

Detailed composition

Substance Quantity Type Category
lorazepamum
2.5 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
120.0 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
carboxymethylamylum natricum A
- Substance HNIDK
magnesii stearas
- Substance HNIDK
natrium
0.25 MG Substance HBESI

Reimbursement information

Public price
CHF 11.65
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2026

Authorization holder

Leman SKL SA

1213 Lancy

Authorization information

Swissmedic authorization number
70235
Drug name
Lorazepam Leman, comprimés
Galenic form
TAB
ATC Code
N05BA06
Authorization status
Z
Dispensation category
B
First authorization
18/12/2025
Authorization expiration date
17/12/2030
IT number
01.04.1.
Domain
Human medicine

Packaging details

Description (FR)
LORAZEPAM Leman cpr 2.5 mg 20 pce
Description (DE)
LORAZEPAM Leman Tabl 2.5 mg 20 Stk
Market launch
01/07/2026
Narcotic (BTM)
B

Original drug

Temesta Expidet, Lyophilisat zum Einnehmen
CHF 12.40
View original

Other packaging sizes

LORAZEPAM Leman cpr 1 mg 20 pce
20 TABL
View
LORAZEPAM Leman cpr 1 mg 50 pce
50 TABL
View
Buy us a coffee Explore the data